PUBLISHER: TechNavio | PRODUCT CODE: 2109393
PUBLISHER: TechNavio | PRODUCT CODE: 2109393
Global Cancer Diagnostic Devices Market 2026-2030
The global cancer diagnostic devices market is forecasted to grow by USD 6385.9 mn during 2025-2030, accelerating at a CAGR of 7.9% during the forecast period. The report on the global cancer diagnostic devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising global incidence of oncological malignancies and demand for early detection, technological advancements in molecular diagnostics and next-generation sequencing, strategic expansion of healthcare infrastructure and screening initiatives in emerging regions.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 7.3% |
| CAGR | 7.9% |
| Incremental Value | $6385.9 mn |
Technavio's global cancer diagnostic devices market is segmented as below:
By Product
- Molecular diagnostics
- Companion diagnostics
By End-User
- Hospitals
- Diagnostic laboratories
- Specialty cancer clinics
- Cancer research institutes
By Type
- Lung cancer
- Breast cancer
- Colorectal cancer
- Prostate cancer
- Others
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- The Netherlands
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the integration of ai and ml in image-guided cancer diagnostics as one of the prime reasons driving the global cancer diagnostic devices market growth during the next few years. Also, shift toward liquid biopsy and non-invasive diagnostic modalities and expansion of point-of-care diagnostic devices and companion diagnostics will lead to sizable demand in the market.
The report on the global cancer diagnostic devices market covers the following areas:
- Global cancer diagnostic devices market sizing
- Global cancer diagnostic devices market forecast
- Global cancer diagnostic devices market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global cancer diagnostic devices market vendors that include Abbott Laboratories, Agilent Technologies Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., Boston Scientific Corp., Bruker Corp., F. Hoffmann La Roche Ltd., FUJIFILM Holdings Corp., GE HealthCare Technologies, Hologic Inc., Illumina Inc., Koninklijke Philips NV, Olympus Corp., PENTAX Medical Co., QIAGEN N.V., Shimadzu Corp., Siemens Healthineers AG, Stryker Corp., Sysmex Corp., Thermo Fisher Scientific Inc.. Also, the global cancer diagnostic devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global Cancer Diagnostic Devices Market 2020 - 2024
- Historic Market Size - Data Table on Global Cancer Diagnostic Devices Market 2020 - 2024 ($ million)
- 5.2 Product segment analysis 2020 - 2024
- Historic Market Size - Product Segment 2020 - 2024 ($ million)
- 5.3 End-user segment analysis 2020 - 2024
- Historic Market Size - End-user Segment 2020 - 2024 ($ million)
- 5.4 Type segment analysis 2020 - 2024
- Historic Market Size - Type Segment 2020 - 2024 ($ million)
- 5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- 5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on Global Cancer Diagnostic Devices Market
- 6.2 Impact of Geopolitical Conflicts on Global Cancer Diagnostic Devices Market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by Product
- 8.1 Market segments
- 8.2 Comparison by Product
- 8.3 Molecular diagnostics - Market size and forecast 2025-2030
- 8.4 Companion diagnostics - Market size and forecast 2025-2030
- 8.5 Market opportunity by Product
- Market opportunity by Product ($ million)
9 Market Segmentation by End-user
- 9.1 Market segments
- 9.2 Comparison by End-user
- 9.3 Hospitals - Market size and forecast 2025-2030
- 9.4 Diagnostic laboratories - Market size and forecast 2025-2030
- 9.5 Specialty cancer clinics - Market size and forecast 2025-2030
- 9.6 Cancer research institutes - Market size and forecast 2025-2030
- 9.7 Market opportunity by End-user
- Market opportunity by End-user ($ million)
10 Market Segmentation by Type
- 10.1 Market segments
- 10.2 Comparison by Type
- 10.3 Lung cancer - Market size and forecast 2025-2030
- 10.4 Breast cancer - Market size and forecast 2025-2030
- 10.5 Colorectal cancer - Market size and forecast 2025-2030
- 10.6 Prostate cancer - Market size and forecast 2025-2030
- 10.7 Others - Market size and forecast 2025-2030
- 10.8 Market opportunity by Type
- Market opportunity by Type ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
- 12.4 Europe - Market size and forecast 2025-2030
- 12.4.1 Germany - Market size and forecast 2025-2030
- 12.4.2 UK - Market size and forecast 2025-2030
- 12.4.3 France - Market size and forecast 2025-2030
- 12.4.4 Italy - Market size and forecast 2025-2030
- 12.4.5 Spain - Market size and forecast 2025-2030
- 12.4.6 Russia - Market size and forecast 2025-2030
- 12.4.7 The Netherlands - Market size and forecast 2025-2030
- 12.5 Asia - Market size and forecast 2025-2030
- 12.5.1 China - Market size and forecast 2025-2030
- 12.5.2 Japan - Market size and forecast 2025-2030
- 12.5.3 India - Market size and forecast 2025-2030
- 12.5.4 South Korea - Market size and forecast 2025-2030
- 12.5.5 Indonesia - Market size and forecast 2025-2030
- 12.5.6 Thailand - Market size and forecast 2025-2030
- 12.5.7 Singapore - Market size and forecast 2025-2030
- 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 12.6.1 Brazil - Market size and forecast 2025-2030
- 12.6.2 Australia - Market size and forecast 2025-2030
- 12.6.3 Turkey - Market size and forecast 2025-2030
- 12.6.4 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.5 South Africa - Market size and forecast 2025-2030
- 12.6.6 UAE - Market size and forecast 2025-2030
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Rising global incidence of oncological malignancies and demand for early detection
- Technological advancements in molecular diagnostics and next-generation sequencing
- Strategic expansion of healthcare infrastructure and screening initiatives in emerging regions
- 13.2 Market challenges
- Exorbitant capital costs and high maintenance expenses of advanced diagnostic equipment
- Stringent regulatory approval frameworks and uncertain reimbursement policies
- Shortage of skilled pathology professionals and complex integration of emerging technologies
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 13.4 Market opportunities
- Integration of AI and ML in image-guided cancer diagnostics
- Shift toward liquid biopsy and non-invasive diagnostic modalities
- Expansion of point-of-care diagnostic devices and companion diagnostics
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 Abbott Laboratories
- Abbott Laboratories - Overview
- Abbott Laboratories - Business segments
- Abbott Laboratories - Key news
- Abbott Laboratories - Key offerings
- Abbott Laboratories - Segment focus
- SWOT
- 15.5 Agilent Technologies Inc.
- Agilent Technologies Inc. - Overview
- Agilent Technologies Inc. - Business segments
- Agilent Technologies Inc. - Key news
- Agilent Technologies Inc. - Key offerings
- Agilent Technologies Inc. - Segment focus
- SWOT
- 15.6 Becton Dickinson and Co.
- Becton Dickinson and Co. - Overview
- Becton Dickinson and Co. - Business segments
- Becton Dickinson and Co. - Key news
- Becton Dickinson and Co. - Key offerings
- Becton Dickinson and Co. - Segment focus
- SWOT
- 15.7 Bio Rad Laboratories Inc.
- Bio Rad Laboratories Inc. - Overview
- Bio Rad Laboratories Inc. - Business segments
- Bio Rad Laboratories Inc. - Key news
- Bio Rad Laboratories Inc. - Key offerings
- Bio Rad Laboratories Inc. - Segment focus
- SWOT
- 15.8 Boston Scientific Corp.
- Boston Scientific Corp. - Overview
- Boston Scientific Corp. - Business segments
- Boston Scientific Corp. - Key offerings
- Boston Scientific Corp. - Segment focus
- SWOT
- 15.9 Bruker Corp.
- Bruker Corp. - Overview
- Bruker Corp. - Business segments
- Bruker Corp. - Key offerings
- Bruker Corp. - Segment focus
- SWOT
- 15.10 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
- 15.11 Hologic Inc.
- Hologic Inc. - Overview
- Hologic Inc. - Product / Service
- Hologic Inc. - Key offerings
- SWOT
- 15.12 Illumina Inc.
- Illumina Inc. - Overview
- Illumina Inc. - Business segments
- Illumina Inc. - Key news
- Illumina Inc. - Key offerings
- Illumina Inc. - Segment focus
- SWOT
- 15.13 PENTAX Medical Co.
- PENTAX Medical Co. - Overview
- PENTAX Medical Co. - Product / Service
- PENTAX Medical Co. - Key offerings
- SWOT
- 15.14 QIAGEN N.V.
- QIAGEN N.V. - Overview
- QIAGEN N.V. - Product / Service
- QIAGEN N.V. - Key offerings
- SWOT
- 15.15 Shimadzu Corp.
- Shimadzu Corp. - Overview
- Shimadzu Corp. - Business segments
- Shimadzu Corp. - Key offerings
- Shimadzu Corp. - Segment focus
- SWOT
- 15.16 Stryker Corp.
- Stryker Corp. - Overview
- Stryker Corp. - Business segments
- Stryker Corp. - Key offerings
- Stryker Corp. - Segment focus
- SWOT
- 15.17 Sysmex Corp.
- Sysmex Corp. - Overview
- Sysmex Corp. - Business segments
- Sysmex Corp. - Key news
- Sysmex Corp. - Key offerings
- Sysmex Corp. - Segment focus
- SWOT
- 15.18 Thermo Fisher Scientific Inc.
- Thermo Fisher Scientific Inc. - Overview
- Thermo Fisher Scientific Inc. - Business segments
- Thermo Fisher Scientific Inc. - Key news
- Thermo Fisher Scientific Inc. - Key offerings
- Thermo Fisher Scientific Inc. - Segment focus
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
